Clinic
White-Wilson Medical Center PA
White-Wilson Medical Center PA was paid $12.68M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoWHITE-WILSON MEDICAL CENTER PA
FORT WALTON BEACH, FL 32547
FORT WALTON BEACH, FL 32547
33aNPI1467437277assigned 12/14/2005
33bProvider typeClinic/Center
28Total paid$12.68M
24GClaims514,953
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Florida
Rank by total paid#4 of 349
Median peer was paid$95K
This provider vs. median134×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,301 | $47K | |
| 2019 | 50,936 | $1.65M | |
| 2020 | 44,959 | $1.32M | |
| 2021 | 82,963 | $2.65M | |
| 2022 | 118,745 | $2.99M | |
| 2023 | 124,792 | $2.68M | |
| 2024incomplete | 80,257 | $1.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 65,458 | 53,642 | $4.06M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 68,789 | 56,882 | $3.27M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 14,808 | 13,198 | $1.45M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.1% | 12,263 | 10,236 | $1.16M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.2% | 42,923 | 25,158 | $665K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.9% | 5,348 | 4,911 | $489K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2.6% | 5,229 | 1,509 | $328K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.3% | 1,628 | 1,494 | $161K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 7,510 | 5,742 | $152K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 13,644 | 11,658 | $128K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,570 | 4,483 | $106K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,986 | 11,341 | $72K |
135 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 13,212 | $51K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,170 | $50K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,854 | $43K |
| 80053 | Comprehensive metabolic panel | <1% | 12,379 | $37K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,615 | $35K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 5,421 | $33K |
| 99243 | <1% | 404 | $32K | |
| 80061 | Lipid panel | <1% | 7,544 | $25K |
| 99490 | Ccm add 20min | <1% | 16,112 | $24K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,161 | $23K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 493 | $21K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 235 | $20K |
| 99381 | <1% | 229 | $17K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 841 | $16K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,763 | $16K |
| 87807 | <1% | 1,453 | $14K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,260 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 522 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,383 | $11K |
| 82728 | <1% | 1,284 | $10K | |
| 84439 | <1% | 2,729 | $10K | |
| 90461 | <1% | 981 | $8K | |
| 92567 | <1% | 695 | $8K | |
| 99051 | <1% | 2,253 | $8K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 614 | $8K |
| 81001 | <1% | 3,582 | $8K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 82 | $7K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 95 | $7K |
| H1000 | Prenatal care, at-risk assessment | <1% | 107 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 154 | $6K |
| 82607 | <1% | 953 | $5K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 141 | $5K |
| 81002 | <1% | 1,868 | $4K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 158 | $4K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 16 | $4K |
| 85027 | <1% | 802 | $3K | |
| 83550 | <1% | 1,384 | $3K | |
| 83540 | <1% | 1,520 | $3K | |
| 87634 | <1% | 43 | $3K | |
| 82746 | <1% | 637 | $3K | |
| 92557 | <1% | 171 | $2K | |
| 81003 | <1% | 880 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 418 | $2K |
| 81025 | <1% | 341 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 918 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 481 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 30 | $1K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 66 | $1K |
| 96127 | <1% | 761 | $1K | |
| 85018 | <1% | 567 | $1K | |
| 93000 | <1% | 217 | $1K | |
| 99460 | <1% | 15 | $972.99 | |
| 82570 | <1% | 1,170 | $841.21 | |
| 99307 | <1% | 205 | $806.59 | |
| 90686 | <1% | 3,767 | $680.58 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 128 | $645.74 |
| 99457 | <1% | 120 | $645.38 | |
| 83655 | <1% | 70 | $644.40 | |
| 99458 | <1% | 61 | $538.55 | |
| 85651 | <1% | 367 | $530.17 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 19 | $511.10 |
| 73630 | <1% | 26 | $505.79 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 14 | $491.25 |
| 96161 | <1% | 431 | $489.38 | |
| 99188 | <1% | 31 | $438.23 | |
| 99454 | <1% | 61 | $422.90 | |
| 82043 | <1% | 703 | $403.96 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 329 | $348.89 |
| 74018 | <1% | 12 | $345.48 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 15 | $330.16 |
| 80050 | General health panel | <1% | 15 | $325.94 |
| 90677 | <1% | 1,270 | $325.00 | |
| 81000 | <1% | 121 | $292.40 | |
| 83970 | <1% | 29 | $271.22 | |
| 90670 | <1% | 6,202 | $241.54 | |
| 85610 | <1% | 199 | $237.00 | |
| 1159F | <1% | 20,562 | $229.55 | |
| 87070 | <1% | 29 | $211.26 | |
| 90651 | <1% | 293 | $202.00 | |
| 90633 | <1% | 2,851 | $160.04 | |
| 85730 | <1% | 50 | $127.64 | |
| 83690 | <1% | 30 | $122.68 | |
| 87081 | <1% | 49 | $117.88 | |
| 90698 | <1% | 4,331 | $116.02 | |
| 86308 | <1% | 24 | $113.64 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 30 | $101.67 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 16 | $93.81 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 12 | $77.94 |
| 82248 | <1% | 16 | $74.99 | |
| 90744 | <1% | 1,286 | $72.03 | |
| 90710 | <1% | 528 | $64.00 | |
| 90734 | <1% | 119 | $64.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 240 | $52.26 |
| 3008F | <1% | 41,008 | $48.27 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 795 | $42.33 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 65 | $41.59 |
| 90697 | <1% | 736 | $35.00 | |
| 83735 | <1% | 139 | $33.48 | |
| 84100 | <1% | 154 | $32.45 | |
| 82274 | <1% | 31 | $26.73 | |
| 90680 | <1% | 3,752 | $25.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 20 | $21.18 |
| 94760 | <1% | 1,672 | $20.00 | |
| 84156 | <1% | 33 | $11.08 | |
| 90688 | <1% | 143 | $10.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 221 | $1.03 |
| 1160F | 0% | 19,338 | $0.00 | |
| 3078F | 0% | 13,959 | $0.00 | |
| 90707 | 0% | 191 | $0.00 | |
| 99173 | 0% | 1,396 | $0.00 | |
| 90700 | 0% | 79 | $0.00 | |
| 90685 | 0% | 97 | $0.00 | |
| 3725F | 0% | 531 | $0.00 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 46 | $0.00 |
| 90671 | 0% | 14 | $0.00 | |
| 90715 | 0% | 75 | $0.00 | |
| 96160 | 0% | 24 | $0.00 | |
| 90648 | 0% | 54 | $0.00 | |
| 3288F | 0% | 24 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 14 | $0.00 |
| 92552 | 0% | 29 | $0.00 | |
| 3074F | 0% | 14,868 | $0.00 | |
| 90656 | 0% | 300 | $0.00 | |
| 90696 | 0% | 118 | $0.00 | |
| 1126F | 0% | 611 | $0.00 | |
| 1125F | 0% | 852 | $0.00 | |
| 1036F | 0% | 365 | $0.00 | |
| 1034F | 0% | 33 | $0.00 | |
| 92551 | 0% | 484 | $0.00 | |
| 3079F | 0% | 416 | $0.00 | |
| 90716 | 0% | 149 | $0.00 | |
| 90619 | 0% | 59 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 13 | $0.00 |
| 1101F | 0% | 20 | $0.00 | |
| 1170F | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEEPER, KATHY (MEDICAL STAFF COORDINATOR)